» Articles » PMID: 10074484

Impairment of Skeletal Muscle Adenosine Triphosphate-sensitive K+ Channels in Patients with Hypokalemic Periodic Paralysis

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1999 Mar 13
PMID 10074484
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

The adenosine triphosphate (ATP)-sensitive K+ (KATP) channel is the most abundant K+ channel active in the skeletal muscle fibers of humans and animals. In the present work, we demonstrate the involvement of the muscular KATP channel in a skeletal muscle disorder known as hypokalemic periodic paralysis (HOPP), which is caused by mutations of the dihydropyridine receptor of the Ca2+ channel. Muscle biopsies excised from three patients with HOPP carrying the R528H mutation of the dihydropyridine receptor showed a reduced sarcolemma KATP current that was not stimulated by magnesium adenosine diphosphate (MgADP; 50-100 microM) and was partially restored by cromakalim. In contrast, large KATP currents stimulated by MgADP were recorded in the healthy subjects. At channel level, an abnormal KATP channel showing several subconductance states was detected in the patients with HOPP. None of these were surveyed in the healthy subjects. Transitions of the KATP channel between subconductance states were also observed after in vitro incubation of the rat muscle with low-K+ solution. The lack of the sarcolemma KATP current observed in these patients explains the symptoms of the disease, i.e., hypokalemia, depolarization of the fibers, and possibly the paralysis following insulin administration.

Citing Articles

Exercise and fatigue: integrating the role of K, Na and Cl in the regulation of sarcolemmal excitability of skeletal muscle.

Renaud J, Ortenblad N, McKenna M, Overgaard K Eur J Appl Physiol. 2023; 123(11):2345-2378.

PMID: 37584745 PMC: 10615939. DOI: 10.1007/s00421-023-05270-9.


Zoledronic Acid Blocks Overactive Kir6.1/SUR2-Dependent K Channels in Skeletal Muscle and Osteoblasts in a Murine Model of Cantú Syndrome.

Scala R, Maqoud F, McClenaghan C, Harter T, Perrone M, Scilimati A Cells. 2023; 12(6).

PMID: 36980269 PMC: 10047381. DOI: 10.3390/cells12060928.


Zoledronic Acid as a Novel Dual Blocker of KIR6.1/2-SUR2 Subunits of ATP-Sensitive K Channels: Role in the Adverse Drug Reactions.

Maqoud F, Scala R, Tragni V, Pierri C, Perrone M, Scilimati A Pharmaceutics. 2021; 13(9).

PMID: 34575427 PMC: 8465290. DOI: 10.3390/pharmaceutics13091350.


Consequences of SUR2[A478V] Mutation in Skeletal Muscle of Murine Model of Cantu Syndrome.

Scala R, Maqoud F, Zizzo N, Passantino G, Mele A, Camerino G Cells. 2021; 10(7).

PMID: 34359961 PMC: 8307364. DOI: 10.3390/cells10071791.


Pathophysiological Consequences of KATP Channel Overactivity and Pharmacological Response to Glibenclamide in Skeletal Muscle of a Murine Model of Cantù Syndrome.

Scala R, Maqoud F, Zizzo N, Mele A, Camerino G, Zito F Front Pharmacol. 2020; 11:604885.

PMID: 33329006 PMC: 7734337. DOI: 10.3389/fphar.2020.604885.


References
1.
Ptacek L, Tawil R, Griggs R, Engel A, Layzer R, Kwiecinski H . Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell. 1994; 77(6):863-8. DOI: 10.1016/0092-8674(94)90135-x. View

2.
Links T, Smit A, OOSTERHUIS H, Reitsma W . Potassium channels in hypokalaemic periodic paralysis: a key to the pathogenesis?. Clin Sci (Lond). 1993; 85(3):319-25. DOI: 10.1042/cs0850319. View

3.
Tricarico D, Camerino D . ATP-sensitive K+ channels of skeletal muscle fibers from young adult and aged rats: possible involvement of thiol-dependent redox mechanisms in the age-related modifications of their biophysical and pharmacological properties. Mol Pharmacol. 1994; 46(4):754-61. View

4.
Jurkat-Rott K, Lehmann-Horn F, Elbaz A, Heine R, Gregg R, Hogan K . A calcium channel mutation causing hypokalemic periodic paralysis. Hum Mol Genet. 1994; 3(8):1415-9. DOI: 10.1093/hmg/3.8.1415. View

5.
Aguilar-Bryan L, Nichols C, Wechsler S, Clement 4th J, Boyd 3rd A, Gonzalez G . Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science. 1995; 268(5209):423-6. DOI: 10.1126/science.7716547. View